Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)
Arcus Biosciences (RCUS) posted quarterly Tax Provisions of $1.0 million for Q4 2024, little changed year-over-year from $1.0 million in Q1 2024, and little changed quarter-over-quarter from $1.0 million in Q4 2023.
Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024) Analysis & Trends
Arcus Biosciences' Tax Provisions history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2024.
- In Q4 2024, Tax Provisions changed 0.0% year-over-year to $1.0 million; the TTM figure through Sep 2025 stood at $1.0 million (changed 0.0% YoY), while the FY2024 annual figure was $1.0 million, down 83.33% from the prior year.
- Tax Provisions for Q4 2024 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
- The five-year high for Tax Provisions was $2.0 million in Q4 2021, with the low at $1.0 million in Q1 2022.
- The 4-year median for Tax Provisions is $1.0 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions jumped 100.0% in 2023, then changed 0.0% in 2024.
- Arcus Biosciences' Tax Provisions stood at $2.0 million in 2021, then slumped by 50.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
- Business Quant data shows RCUS's Tax Provisions at $1.0 million in Q4 2024, $1.0 million in Q4 2023, and $2.0 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 2.00 Mn |